loadpatents
name:-0.023161172866821
name:-0.020642995834351
name:-0.014546155929565
Owen; Dafydd Rhys Patent Filings

Owen; Dafydd Rhys

Patent Applications and Registrations

Patent applications and USPTO patent grants for Owen; Dafydd Rhys.The latest application filed is for "nitrile-containing antiviral compounds".

Company Profile
8.14.18
  • Owen; Dafydd Rhys - Concord MA
  • Owen; Dafydd Rhys - Cambridge MA
  • Owen; Dafydd Rhys - Sandwich GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Nitrile-containing antiviral compounds
Grant 11,452,711 - Owen , et al. September 27, 2
2022-09-27
Nitrile-Containing Antiviral Compounds
App 20220257563 - Owen; Dafydd Rhys ;   et al.
2022-08-18
Nitrile-containing antiviral compounds
Grant 11,351,149 - Owen , et al. June 7, 2
2022-06-07
Nitrile-Containing Antiviral Compounds
App 20220142976 - Owen; Dafydd Rhys ;   et al.
2022-05-12
Nitrile-Containing Antiviral Compounds
App 20220062232 - Owen; Dafydd Rhys ;   et al.
2022-03-03
Pyrazolo[1,5-A]pyrazin-4-yl and related derivatives
Grant 11,254,668 - Gerstenberger , et al. February 22, 2
2022-02-22
Compounds and Methods for the Treatment of COVID-19
App 20220017548 - Kania; Robert Steven ;   et al.
2022-01-20
Pyrazolo[1,5-a]pyrazin-4-yl Derivatives
App 20200399281 - BROWN; Matthew Frank ;   et al.
2020-12-24
Pyrazolo[1,5-a]pyrazin-4-yl derivatives
Grant 10,822,341 - Brown , et al. November 3, 2
2020-11-03
Pyrazolo[1,5-a]pyrazin-4-yl And Related Derivatives
App 20200172537 - Gerstenberger; Brian Stephen ;   et al.
2020-06-04
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
Grant 10,316,018 - Lee , et al.
2019-06-11
Bicyclic-fused Heteroaryl Or Aryl Compounds As Irak4 Modulators
App 20190092750 - LEE; KATHERINE LIN ;   et al.
2019-03-28
Pyrazolo[1,5-a]pyrazin-4-yl Derivatives
App 20190071448 - BROWN; Matthew Frank ;   et al.
2019-03-07
Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
Grant 10,174,000 - Lee , et al. J
2019-01-08
Pyrazolo[1,5-A]PYRAZIN-4-YL derivatives
Grant 10,144,738 - Brown , et al. De
2018-12-04
Bicyclic-fused Heteroaryl Or Aryl Compounds As Irak4 Modulators
App 20180244646 - LEE; KATHERINE LIN ;   et al.
2018-08-30
Substituted pyridazines for the treatment of pain
Grant 10,016,420 - Gibson , et al. July 10, 2
2018-07-10
Pyrazolo[1,5-a]pyrazin-4-yl Derivatives
App 20170240552 - BROWN; Matthew Frank ;   et al.
2017-08-24
Substituted Pyridazines For The Treatment Of Pain
App 20160287584 - Gibson; Karl Richard ;   et al.
2016-10-06
Substituted pyridazines for the treatment of pain
Grant 9,273,011 - Gibson , et al. March 1, 2
2016-03-01
Enkephalin analogues
Grant 8,957,025 - Owen February 17, 2
2015-02-17
Pyridazine Derivatives Useful In Therapy
App 20140275100 - Gibson; Karl Richard ;   et al.
2014-09-18
Enkephalin Analogues
App 20140121279 - Owen; Dafydd Rhys
2014-05-01
Peptide analogues
Grant 8,598,123 - Barber , et al. December 3, 2
2013-12-03
Peptide Analogues
App 20120329724 - Barber; Christopher Gordon ;   et al.
2012-12-27
Peptide Analogues
App 20110207654 - Barber; Christopher Gordon ;   et al.
2011-08-25
Pyrazolo[4,3-D]pyrimidines
Grant 7,569,572 - Bell , et al. August 4, 2
2009-08-04
Pyrazolo[4,3-D]Pyrimidines
App 20080293697 - Bell; Andrew Simon ;   et al.
2008-11-27
Novel pharmaceuticals
App 20040138274 - Dack, Kevin Neil ;   et al.
2004-07-15

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed